These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2737791)

  • 21. Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site Administration.
    Kidd JM; Avery LM; Asempa TE; Nicolau DP; Kuti JL
    Clin Ther; 2018 Feb; 40(2):261-269. PubMed ID: 29290374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection.
    Outman WR; Monolakis J
    Am J Hosp Pharm; 1991 Jul; 48(7):1539-41. PubMed ID: 1882889
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
    Avery LM; Chen IH; Reyes S; Nicolau DP; Kuti JL
    Clin Ther; 2019 Oct; 41(10):2162-2170. PubMed ID: 31506218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Jun; 45(6):1357-8. PubMed ID: 3414706
    [No Abstract]   [Full Text] [Related]  

  • 25. A new fractional wavelet approach for the simultaneous determination of ampicillin sodium and sulbactam sodium in a binary mixture.
    Dinç E; Baleanu D
    Spectrochim Acta A Mol Biomol Spectrosc; 2006 Mar; 63(3):631-8. PubMed ID: 16024281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability and compatibility of minocycline hydrochloride and rifampin in intravenous solutions at various temperatures.
    Pearson SD; Trissel LA
    Am J Hosp Pharm; 1993 Apr; 50(4):698-702. PubMed ID: 8470688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of visual and turbidimetric methods for determining short-term compatibility of intravenous critical-care drugs.
    Dasta JF; Hale KN; Stauffer GL; Tschampel MM
    Am J Hosp Pharm; 1988 Nov; 45(11):2361-6. PubMed ID: 3228093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride.
    Moursy NM; Afifi NN; Ghorab DM; El-Saharty Y
    Pharmazie; 2003 Jan; 58(1):38-43. PubMed ID: 12622251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF; Kim MC
    Am J Health Syst Pharm; 1997 Oct; 54(19):2192-6. PubMed ID: 9331439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical compatibility of tedizolid phosphate with selected i.v. drugs during simulated Y-site administration.
    Ghazi I; Hamada Y; Nicolau DP
    Am J Health Syst Pharm; 2016 Nov; 73(21):1769-1776. PubMed ID: 27769972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compatibility of propranolol hydrochloride injection with intravenous infusion fluids in plastic containers.
    Cummings DS; Park MK; Howard AB
    Am J Hosp Pharm; 1982 Oct; 39(10):1685-7. PubMed ID: 7148843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of morphine sulfate and meperidine hydrochloride in a parenteral nutrient formulation.
    Macias JM; Martin WJ; Lloyd CW
    Am J Hosp Pharm; 1985 May; 42(5):1087-94. PubMed ID: 3923832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Incompatibility reactions in the intensive care unit. Five years after the implementation of a simple "colour code system"].
    Vogel Kahmann I; Bürki R; Denzler U; Höfler A; Schmid B; Splisgardt H
    Anaesthesist; 2003 May; 52(5):409-12. PubMed ID: 12750824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compatibility and stability of labetalol hydrochloride in commonly used intravenous solutions.
    Yuen PH; Taddei CR; Wyka BE; Chaudry IA
    Am J Hosp Pharm; 1983 Jun; 40(6):1007-9. PubMed ID: 6869384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-sectional study of potential incompatibility of intravenous medications in a Neonatal Intensive Care Unit in Indonesia.
    Mahendra AD; Hanifah S; Sari CP
    Farm Hosp; 2023; 47(1):T16-T19. PubMed ID: 36707310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22, and 32 degrees C.
    Trissel LA; Xu Q; Martinez JF; Fox JL
    Am J Hosp Pharm; 1994 Sep; 51(17):2138-42. PubMed ID: 7527184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual compatibility of fentanyl citrate with selected drugs during simulated Y-site injection.
    Marquardt ED; Lam SS
    Am J Hosp Pharm; 1994 Mar; 51(6):811-2. PubMed ID: 8010323
    [No Abstract]   [Full Text] [Related]  

  • 38. Prospective randomized comparison of safety and efficacy of nicardipine and nitroprusside drip for control of hypertension in the neurosurgical intensive care unit.
    Roitberg BZ; Hardman J; Urbaniak K; Merchant A; Mangubat EZ; Alaraj A; Mlinarevich N; Watson KS; Ruland S
    Neurosurgery; 2008 Jul; 63(1):115-20; discussion 120-1. PubMed ID: 18728576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection.
    Souney PF; Colucci RD; Mariani G; Campbell D
    Am J Hosp Pharm; 1984 Feb; 41(2):323-4. PubMed ID: 6702842
    [No Abstract]   [Full Text] [Related]  

  • 40. Visual compatibility of ranitidine hydrochloride with commonly used critical-care medications.
    Chilvers MR; Lysne JM
    Am J Hosp Pharm; 1989 Oct; 46(10):2057-8. PubMed ID: 2816963
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.